Overview

Update
Status
Acquired by on February 11, 2014
IPO / Stock
Went Public on Oct 25, 2006 / NASDAQ:CADX
Headquarters:
San Diego, CA
Description:
Cadence Pharmaceuticals is a manufactures of medicines , especially pain management solutions.
Founders:
Categories:
Biotechnology
Website:
http://www.cadencepharm.com
Social:

Company Details

Update

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.

Funding Rounds (1) - undisclosed

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2008undisclosed amount / Seed1

Investors (1)

InvestorRound(s)Partner(s)
Seed-

Current Team (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    12481 High Bluff Drive

    Suite 200

    San Diego, CA 92130

    USA

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos